News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Soni Manmeet Singh
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 62,621 shares
@ $0
Disposed/sold 24,000 options to buy
@ $121.29, valued at
$2.9M
Disposed/sold 75,000 options to buy
@ $27.32, valued at
$2M
Disposed/sold 75,000 options to buy
@ $34.15, valued at
$2.6M
Disposed/sold 95,475 options to buy
@ $36.71, valued at
$3.5M
Disposed/sold 175,000 options to buy
@ $72.7, valued at
$12.7M
Disposed/sold 50,000 options to buy
@ $104.79, valued at
$5.2M
Disposed/sold 25,000 options to buy
@ $207.2, valued at
$5.2M
|
|
| 08/17/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 1,755 shares
@ $168.4135, valued at
$295.6k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/10/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 6,000 shares
@ $0 |
|
| 06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.95, valued at
$119k
|
|
| 05/17/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 12,440 shares
@ $84.3201, valued at
$1M
Sold 8,867 shares
@ $84.8648, valued at
$752.5k
Sold 200 shares
@ $85.6425, valued at
$17.1k
Sold 625 shares
@ $80.934, valued at
$50.6k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 50,000 shares
@ $0
Granted 50,000 options to buy
@ $104.79, valued at
$5.2M
|
|
| 03/08/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 622 shares
@ $84.695, valued at
$52.7k
|
|
| 03/06/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 3,587 shares
@ $87.97, valued at
$315.5k
|
|
| 03/01/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 75,000 options to buy
@ $34.15, valued at
$2.6M
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Soni Manmeet Singh (COO and CFO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $27.32, valued at
$2.7M
|
|
| 01/05/2022 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.82, valued at
$70.5k
Granted 82,446 options to buy
@ $2.82, valued at
$232.5k
|
|
| 01/04/2022 |
4
| Soni Manmeet Singh (COO and CFO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Bought 16,000 shares
@ $26.2228, valued at
$419.6k
|
|
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2020 |
3
| Soni Manmeet Singh (Director) has filed a Form 3 on Summit Therapeutics Inc. |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Sold 304 shares
@ $62.74, valued at
$19.1k
|
|
| 06/16/2020 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,446 shares
@ $0
Sold 1,327 shares
@ $60.12, valued at
$79.8k
Granted 5,000 options to buy
@ $61.31, valued at
$306.6k
|
|
| 05/19/2020 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.66, valued at
$213.2k
|
|
| 01/06/2020 |
4
| Soni Manmeet Singh (CFO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $207.2, valued at
$5.2M
|
|
| 08/29/2019 |
4
| Soni Manmeet Singh (CFO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 250,000 options to buy
@ $72.7, valued at
$18.2M
|
|
| 08/29/2019 |
3
| Soni Manmeet Singh (CFO) has filed a Form 3 on REATA PHARMACEUTICALS INC |
| 06/17/2019 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,654 shares
@ $0
Sold 1,084 shares
@ $55.8172, valued at
$60.5k
Sold 133 shares
@ $56.5116, valued at
$7.5k
Granted 5,000 options to buy
@ $56.5, valued at
$282.5k
|
|
|
|
|